Loopbaan van Karen B. Chapman
Eerdere bekende functies van Karen B. Chapman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCOCYTE CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-04-2011 | 22-03-2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Oprichter | - | - |
Opleiding van Karen B. Chapman
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Cornell University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
- Beurs
- Insiders
- Karen B. Chapman
- Ervaring
